http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-35091-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_034bfd56a60f64c13aedf7b0e71dead6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a17929100d05322db06ab641a792dea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c196913c895e8dd35109d76a17dcff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d85e009e0aab18e364aad4191245426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02a6b5abc363950fe9d080e66cc6cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a602ce2a2954d4da9601065a46acad81
publicationDate 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-35091-A
titleOfInvention MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
abstract The specification presents modified-release pharmaceutical formulations (eg, extended-release pharmaceutical formulations; for example, solid pharmaceutical forms, for example, tablets) that are useful for oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to an animal or human subject as well as methods of preparing and using said formulations
priorityDate 2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25067547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413980434

Total number of triples: 38.